1919 Investment Counsel’s Quest Diagnostics DGX Stock Holding History

1919 Investment Counsel’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$768K	Sell	12,647 -300	-2%	-$18.5K	0.02%	416
2014 Q2	$760K	Sell	12,947 -400	-3%	-$23.4K	0.02%	419
2014 Q1	$774K	Sell	13,347 -1,800	-12%	-$96.5K	0.02%	402
2013 Q4	$811K	Sell	15,147 -2,827	-16%	-$168K	0.02%	401
2013 Q3	$1.11M	Sell	17,974 -7,300	-29%	-$437K	0.03%	360
2013 Q2	$1.53M	Buy	+25,274	New	+$1.51M	0.04%	311

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

1919 Investment Counsel's DGX Position: Q3 2014 in Review

1919 Investment Counsel reduced its Quest Diagnostics (DGX) stake by 2.3% in Q3 2014, selling an estimated $18.5K and leaving 12,647 shares worth $768K. The position accounts for 0.02% of the portfolio, ranked #416.

1919 Investment Counsel first reported a position in DGX in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.53M in Q2 2013. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

1919 Investment Counsel held 12,647 shares of Quest Diagnostics worth $768K as of Q3 2014.
1919 Investment Counsel sold 300 Quest Diagnostics shares in Q3 2014, an estimated $18.5K.
Quest Diagnostics made up 0.02% of 1919 Investment Counsel's portfolio in Q3 2014, its #416 holding.
1919 Investment Counsel first reported a position in Quest Diagnostics in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Quest Diagnostics position peaked at $1.53M in Q2 2013.
485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.